Sindlev Rene 13D and 13G filings for DANDRIT BIOTECH USA:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 4:08 pm Purchase |
2023-08-01 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 14,945,971 20.900% |
1,084,500 (+7.82%) |
Filing |
| 2024-01-24 4:08 pm Purchase |
2023-06-26 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 13,861,471 23.300% |
2,830,191 (+25.66%) |
Filing |
| 2024-01-24 4:07 pm Purchase |
2023-03-17 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 11,031,280 19.600% |
1,328,472 (+13.69%) |
Filing |
| 2024-01-24 4:07 pm Purchase |
2021-09-24 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,702,808 18.600% |
17,557 (+0.18%) |
Filing |
| 2024-01-24 4:06 pm Purchase |
2019-09-30 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,685,251 20.900% |
170,114 (+1.79%) |
Filing |
| 2024-01-24 4:05 pm Purchase |
2018-12-27 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,515,137 24.200% |
94,268 (+1.00%) |
Filing |
| 2024-01-24 4:05 pm Unchanged |
2018-02-16 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,420,869 23.200% |
0 (Unchanged) |
Filing |
| 2024-01-24 4:04 pm Purchase |
2017-10-13 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,420,869 48.600% |
250,000 (+2.73%) |
Filing |
| 2024-01-24 4:04 pm Purchase |
2017-04-21 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 9,170,869 51.400% |
8,100,000 (+756.40%) |
Filing |
| 2024-01-24 4:03 pm Purchase |
2016-03-14 | 13D | DANDRIT BIOTECH USA DDRT |
Sindlev Rene | 1,070,869 11.200% |
1,070,869 (New Position) |
Filing |